mRNA Vaccines against SARS-CoV-2: Advantages and Caveats

The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has constituted a determinant resource to control the COVID-19 pandemic. Since the beginning of 2021, millions of doses have been administered in several countries of North and South America and Europe. Many studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Echaide, Miriam, Chocarro de Erauso, Luisa, Bocanegra, Ana, Blanco, Ester, Kochan, Grazyna, Escors, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051235/
https://www.ncbi.nlm.nih.gov/pubmed/36983017
http://dx.doi.org/10.3390/ijms24065944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051235/
https://www.ncbi.nlm.nih.gov/pubmed/36983017
http://dx.doi.org/10.3390/ijms24065944

Ejemplares similares